Lucid Group (LCID) Prices $1.75B Convertible Senior Notes Offering

Lucid Group (LCID) Gains 5% in Early Trading

Lucid Group (NASDAQ: LCID) gains 5% off the open after yesterday's plunge on the Convertible Notes offering, which has now priced.

Popular stocks with increasing volume: CHWY ROKU GME DOCU SNAP LCID

Popular stocks with increasing volume: CHWY ROKU GME DOCU SNAP LCID

Lucid Group (LCID) continues to drift lower after proposed convertible notes offering

Lucid Group (NASDAQ: LCID) continues to drift lower after proposed convertible notes offering, now down 12.7%.

Pre-Open Stock Movers 12/09: (IINN) (AVCT) (RH) Higher; (RETA) (RLMD) (GME) Lower (more...)

Pre-Open Movers:

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) 113% HIGHER; signed an exclusive summary distribution agreement with Innovimed Sp. z o.o ("Innovimed"), a master distributor specializing in state-of-the-art medical solutions in Eastern Europe, Middle East and Africa. The Innovimed leadership team, have decades of experience with sales, marketing and distribution with medical devices in global healthcare industry companies including Baxter (AG).

Reata Pharmaceuticals, Inc. (Nasdaq:... More

EV Lucid Group (LCID) Shares Down 6% Today. Here's Why

Shares of Lucid Group (NASDAQ: LCID) are set to open 6% lower today after the company announced yesterday after market close that it plans to sell $1.75 billion of convertible senior notes.

Initial buyers will also have an option to buy a further $262.5... More

Stocks expected to have increasing option volume: TSN ADM CVS RENT LCID

Stocks expected to have increasing option volume: TSN ADM CVS RENT LCID

After-Hours Stock Movers 12/08: (RH) (STRM) (APTX) Higher; (RLMD) (GME) (LCID) Lower (more...)

After-Hours Movers:

RH (NYSE: RH) 10.8% HIGHER; reported Q3 EPS of $7.03, $0.39 better than the analyst estimate of $6.64. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $985.18 million. Now expect fiscal 2021 revenue growth of 32% to 33% versus our prior outlook of 31% to 33%, and adjusted operating margin in the range of 25.3% to 25.5% versus our prior outlook of 24.9% to 25.5%.

Relmada Therapeutics, Inc. (Nasdaq: RLMD) 10.4% LOWER; announced its intention to offer and sell $100 million of shares of its common stock... More

Lucid Group (LCID) Announces $1.75B Proposed Convertible Senior Notes Offering

Lucid Group, Inc. ("Lucid")(Nasdaq: LCID) today announced its intention to offer, subject to market and other conditions, $1,750,000,000 aggregate principal amount of convertible senior notes due 2026 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Lucid also expects to grant the initial purchasers of the notes an option, for settlement within a period of 13 days from, and including, the date the notes are first issued, to purchase up to an additional $262,500,000 principal... More